210 related articles for article (PubMed ID: 31884373)
21. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
Yumlu S; Bashir S; Stumm J; Kühn R
Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
[TBL] [Abstract][Full Text] [Related]
22. Generation of a gene-corrected human isogenic line (UAMi006-A) from propionic acidemia patient iPSC with an homozygous mutation in the PCCB gene using CRISPR/Cas9 technology.
Fulgencio-Covián A; Álvarez M; Pepers BA; López-Márquez A; Ugarte M; Pérez B; van Roon-Mom WMC; Desviat LR; Richard E
Stem Cell Res; 2020 Dec; 49():102055. PubMed ID: 33128956
[TBL] [Abstract][Full Text] [Related]
23. Generation and characterization of a human iPSC line and gene-corrected isogenic line derived from a patient with a CELF2 gene mutation.
Hua M; Williams L; Burns K; Liu S; Ellis J; Innes AM; McPherson M; Yang G
Stem Cell Res; 2024 Apr; 76():103344. PubMed ID: 38364506
[TBL] [Abstract][Full Text] [Related]
24. Generation of a CLTA reporter human induced pluripotent stem cell line, CRMi001-A-1, using the CRISPR/Cas9 system to monitor endogenous clathrin trafficking.
Anderson RH; Kerkvliet JG; Otta JJ; Ross AD; Leiferman PC; Hoppe AD; Francis KR
Stem Cell Res; 2018 Dec; 33():95-99. PubMed ID: 30340091
[TBL] [Abstract][Full Text] [Related]
25. Generation of a homozygous ABCA7-knockout human iPSC line using the CRISPR/Cas9 system.
Guan M; Chai Y; Yi R; Chen Y; Ip JPK; Ye T; Chen Y
Stem Cell Res; 2023 Feb; 66():103000. PubMed ID: 36521383
[TBL] [Abstract][Full Text] [Related]
26. Generation of RUNX1c-eGFP induced pluripotent stem cell, MUSIi012-A-4, using CRISPR/Cas9.
Srisook P; Laowtammathron C; Lorthongpanich C; Klaihmon P; Terbto P; Waeteekul S; U-Pratya Y; Issaragrisil S
Stem Cell Res; 2023 Mar; 67():103035. PubMed ID: 36753833
[TBL] [Abstract][Full Text] [Related]
27. Generation of a heterozygous TPM1-E192K knock-in human induced pluripotent stem cell line using CRISPR/Cas9 system.
Kang JY; Mun D; Chun Y; Kim H; Yun N; Lee SH; Joung B
Stem Cell Res; 2022 Aug; 63():102878. PubMed ID: 35917600
[TBL] [Abstract][Full Text] [Related]
28. CRISPR/Cas9-mediated generation of a tyrosine hydroxylase reporter iPSC line for live imaging and isolation of dopaminergic neurons.
Calatayud C; Carola G; Fernández-Carasa I; Valtorta M; Jiménez-Delgado S; Díaz M; Soriano-Fradera J; Cappelletti G; García-Sancho J; Raya Á; Consiglio A
Sci Rep; 2019 May; 9(1):6811. PubMed ID: 31048719
[TBL] [Abstract][Full Text] [Related]
29. Using CRISPR/Cas9 to generate a heterozygous COL2A1 p.R719C iPSC line (MCRIi019-A-6) model of human precocious osteoarthritis.
Yammine KM; Mirda Abularach S; Sampurno L; Bateman JF; Lamandé SR; Shoulders MD
Stem Cell Res; 2023 Mar; 67():103020. PubMed ID: 36682125
[TBL] [Abstract][Full Text] [Related]
30. Rhesus iPSC Safe Harbor Gene-Editing Platform for Stable Expression of Transgenes in Differentiated Cells of All Germ Layers.
Hong SG; Yada RC; Choi K; Carpentier A; Liang TJ; Merling RK; Sweeney CL; Malech HL; Jung M; Corat MAF; AlJanahi AA; Lin Y; Liu H; Tunc I; Wang X; Palisoc M; Pittaluga S; Boehm M; Winkler T; Zou J; Dunbar CE
Mol Ther; 2017 Jan; 25(1):44-53. PubMed ID: 28129126
[TBL] [Abstract][Full Text] [Related]
31. Generation of an OCT3/4 reporter cynomolgus monkey ES cell line using CRISPR/Cas9.
Kobayashi K; Tsukiyama T; Nakaya M; Kageyama S; Tomita K; Murai R; Yoshida T; Narita M; Kawauchi A; Ema M
Stem Cell Res; 2019 May; 37():101439. PubMed ID: 31005787
[TBL] [Abstract][Full Text] [Related]
32. Generation of a human induced pluripotent stem cell line JHUi003-A with homozygous mutation for spinocerebellar ataxia type 12 using genome editing.
Feng H; Li Q; Margolis RL; Li PP
Stem Cell Res; 2021 May; 53():102346. PubMed ID: 34087983
[TBL] [Abstract][Full Text] [Related]
33. Generation of a TMEM43 knockout human induced pluripotent stem cell line (HDZi003-A-1) using CRISPR/Cas9.
Ratnavadivel S; Dammeier J; Gaertner A; de Toledo MAS; Zenke M; Gummert J; Bloch Rasmussen T; Klinke N; Jürgens K; Meyer H; Paululat A; Milting H
Stem Cell Res; 2024 Apr; 76():103354. PubMed ID: 38430734
[TBL] [Abstract][Full Text] [Related]
34. Generation of a gene corrected human isogenic IBMS-iPSC-014-C from polycystic-kidney-disease induced pluripotent stem cell line using CRISPR/Cas9.
Liu CL; Huang CY; Chen HC; Lu HE; Hsieh PCH; Lee JJ
Stem Cell Res; 2020 May; 45():101784. PubMed ID: 32361310
[TBL] [Abstract][Full Text] [Related]
35. Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.
Han HJ; Seo HH; Han HW; Kim JH
Stem Cell Res; 2019 Oct; 40():101520. PubMed ID: 31445394
[TBL] [Abstract][Full Text] [Related]
36. Creating a patient carried Men1 gene point mutation on wild type iPSCs locus mediated by CRISPR/Cas9 and ssODN.
Guo D; Liu H; Gao G; Liu Y; Zhuang Y; Yang F; Wang K; Zhou T; Qin D; Hong L; Li J; Xu K; Li YX
Stem Cell Res; 2017 Jan; 18():67-69. PubMed ID: 28395809
[TBL] [Abstract][Full Text] [Related]
37. Generation of induced pluripotent stem cell line (TMOi001-A-11) carrying a homozygous deletion in the synemin gene using CRISPR/Cas9.
Gargano C; Vartanian-Grimaldi JS; Hovhannisyan Y; Joanne P; Agbulut O; Li Z; Parlakian A; Decaux JF
Stem Cell Res; 2023 Dec; 73():103254. PubMed ID: 38035530
[TBL] [Abstract][Full Text] [Related]
38. Modeling of dilated cardiomyopathy by establishment of isogenic human iPSC lines carrying phospholamban C25T (R9C) mutation (UPITTi002-A-1) using CRISPR/Cas9 editing.
Barndt RJ; Ma N; Tang Y; Haugh MP; Alamri LS; Chan SY; Wu H
Stem Cell Res; 2021 Oct; 56():102544. PubMed ID: 34583280
[TBL] [Abstract][Full Text] [Related]
39. CRISPR/Cas9 editing to generate a heterozygous COL2A1 p.G1170S human chondrodysplasia iPSC line, MCRIi019-A-2, in a control iPSC line, MCRIi019-A.
Kung LHW; Sampurno L; Yammine KM; Graham A; McDonald P; Bateman JF; Shoulders MD; Lamandé SR
Stem Cell Res; 2020 Oct; 48():101962. PubMed ID: 33002832
[TBL] [Abstract][Full Text] [Related]
40. Generation of gene corrected human isogenic iPSC lines (IDVi003-A_CR13, IDVi003-A_CR21, IDVi003-A_CR24) from an inherited retinal dystrophy patient-derived IPSC line ITM2B-5286-3 (IDVi003-A) carrying the ITM2B c.782A > C variant using CRISPR/Cas9.
Ben Yacoub T; Letellier C; Wohlschlegel J; Condroyer C; Slembrouck-Brec A; Goureau O; Zeitz C; Audo I
Stem Cell Res; 2023 Sep; 71():103166. PubMed ID: 37473460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]